3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Retinoblastoma
14
Sarcoma
3
Medulloblastoma
3
Hepatoblastoma
3
Central Nervous System Neoplasms
3
Wilms Tumor
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Liver Neoplasms
2
Kidney Neoplasms
2
Carcinoma, Renal Cell
2
Brain Neoplasms
2
Astrocytoma
2
Unspecified Childhood Solid Tumor, Protocol Specific
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Testicular Neoplasms
1
Teratoma
1
Sarcoma, Ewing
1
Retinal Neoplasms
1
Ovarian Neoplasms
1
Ovarian Germ Cell Cancer
1
Optic Nerve Glioma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroectodermal Tumors
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Glioma
1
Familial ependymoma
1
Eye Neoplasms
1
Ependymoma
1
Interventions
Etoposide
3
Carboplatin
3
Vincristine
2
Topotecan
1
Platinum Compounds
1
Melphalan
1
Lasers, Semiconductor
1
Lasers
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Eye Enucleation
1
Drug Therapy
1
Doxorubicin
1
Cyclophosphamide
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Retinal Neoplasms
×
Melphalan
×
Other solid neoplasm
×
Clear all
NCT02866136
2025-11-24
RETINO2011
Institut Curie
Phase 2
Active not recruiting
133 enrolled